Patients having opioid (heroin) addiction receive buprenorphine treatment in hospital, but seamlessly connecting them with an outpatient office based treatment program can greatly reduce relapse after they are discharged, demonstrate results of a new study.
Led by researchers at Boston Medical Center (BMC), the study shows the important role that providers play in offering these patients addiction treatment both while in the hospital and after - even if their primary reason for being in the hospital is not for their addiction. In this study, 139 hospitalized individuals with opioid addiction who were not already in treatment were randomized into two groups.
Drug Rehabilitation Gives Life a Chance
Authorized Drug Rehabilitation Center can salvage the lives of victims of drug abuse or substance abuse and their pained families, confirm team at Serene Life Hospital for de-addiction and rehabilitation, Chennai, India.
Advertisement
One group received a tapered dose treatment of buprenorphine for withdrawal and referral information about community treatment programs and the other were initiated on buprenorphine, an opioid substitute proven to treat opioid addiction, along with referral to a primary care office-based buprenorphine treatment program. Buprenorphine, which was approved by the Food and Drug Administration in 2002 for the treatment of opioid addiction, is taken orally and helps to curb opioid withdrawal symptoms. Of those in the buprenorphine maintenance group, more than one third (37 percent) reported no illicit opioid/drug use for the month after they left the hospital compared to less than one in ten (nine percent) among the control group.
These patients also reported, on average, fewer days of illicit drug use and continued to use less over the following six months. This effect was evident despite the fact that these patients did not initially come to the hospital seeking treatment for their addiction. "Unfortunately, referral to substance abuse treatment after discharge is often a secondary concern of physicians caring for hospitalized patients," said Jane Liebschutz, MD, MPH, a physician in general internal medicine at BMC and associate professor of medicine at Boston University School of Medicine, who served as the study's corresponding author. "However, our results show that we can have a marked impact on patient's addiction by addressing it during their hospitalization."
Source: Eurekalert
Source: Eurekalert
Dominant Discoveries and The Darker Side Of Methamphetamine Drug Addiction
Antidepressant therapy with bupropion may hold the key towards methamphetamine addiction
Advertisement
 Europe's 'Largest Ever' Heroin Seizure In GreeceMore than two tonnes of heroin has been discovered in Greek warehouses in as many weeks in what authorities claim to be Europe's largest ever seizure of the drug. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
